Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI).
about
Cognitive impairments in multiple sclerosis: a review.Assessing executive function with the D-KEFS sorting test: normative data for a sample of the Italian adult population.Cognitive changes in multiple sclerosis.Reliable screening for neuropsychological impairment in multiple sclerosis.Evolving expectations around early management of multiple sclerosis.Relationship between stress and relapse in multiple sclerosis: Part I. Important features.Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships.Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire.Cognitive screening in multiple sclerosis.Diagnostics of cognitive dysfunctions in multiple sclerosis.Relationship between psychosocial factors and onset of multiple sclerosis.Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.Neuropsychological measures in clinical practice.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.Fluency in multiple sclerosis: which measure is best?Canadian Normative Data for Minimal Assessment of Cognitive Function in Multiple Sclerosis.Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).Evidence for deficits in facial affect recognition and theory of mind in multiple sclerosis.Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model.The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.One-year cyclophosphamide treatment combined with methylprednisolone improves cognitive dysfunction in progressive forms of multiple sclerosis.A short neuropsychological evaluation of patients with primary Sjögren's syndrome.Practical methods for the clinical assessment of information processing speed.Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.Prospective memory, emotional valence, and multiple sclerosis.Evaluating Neurocognitive Deficits in Patients With Multiple Sclerosis Via a Brief Neuropsychological Approach.Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country.Cognitive Impairment in Multiple Sclerosis.The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study.Comparison of two brief neuropsychological batteries in people with multiple sclerosis.A brief neuropsychological screening test battery for cognitive dysfunction in Brazilian multiple sclerosis patients.Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.Three screening batteries to detect cognitive impairment in multiple sclerosis.Impairments of attention in individuals with multiple sclerosis.An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis.What can we learn from the personal insights of individuals living and coping with multiple sclerosis?
P2860
Q30671631-BB48DA65-DD83-48A2-8F81-5EAD3E0E68E0Q30835239-76CD6252-C2FA-4410-95B3-A42476760D60Q33377548-8CA64FCA-2FC8-4FC9-B584-16984E8066EEQ34374334-C8F91193-F56A-47FC-83FB-D71E0FD2800DQ34409412-F4248958-D626-4EAC-9CD3-E06327862106Q34569849-FCA5846C-2BC0-4631-9A47-EBB480D7A09EQ34569853-6C2B4069-FA22-477B-ABF2-2DE115448E3BQ35078171-F84572F7-1E30-4EF8-A743-EE282A268322Q36822070-CCA12A47-AB18-44FA-9D70-CF68139BB6FCQ36822075-5733C0C4-9F87-4FB4-BCAE-6912C713C122Q37466760-8BB1B786-6E17-473D-90B5-A40DBD45A9B0Q37704428-0D85E8C9-3D68-4A70-830A-33AAD4D17A85Q37776426-926A4856-C8B1-404D-A59E-DE5D1243BF14Q37800214-32752763-2C72-4D5E-BC56-AC862B0A2366Q38433415-B8937C06-944C-4DD9-B8DD-22C31C289D9EQ38690615-7E89B84A-F4FE-4AB9-ADF1-EFBAF30D0C09Q39698060-614A1994-6485-415E-ABEE-61578A382CE4Q40004187-AE4C7EF2-D34C-4FF2-A9F1-89052ADFFC47Q40159597-BA96E05D-4357-4B73-AB41-2C978BCC09ABQ42614436-79459EE1-ADB2-4DC6-BB32-3395865884DAQ43737031-B3BDDCCC-8162-40D7-9CF9-F914BDF6C618Q46548047-960DF46B-287B-4998-98AD-019873C71AE9Q48332716-2885EF64-30E9-4D17-B3CB-539C43BD1C33Q48413450-A20AB641-97E4-4166-8135-9AEC0ED04D70Q48760113-5E25AE33-D3E1-48AE-9246-83042D1CD255Q50584103-FD7CFCCF-8EB1-4C5B-B26F-175B0247D681Q50748985-4AD79920-5648-4E3C-8C28-D2CBE98F2503Q50784220-2D2D779B-ACD2-4F6B-98D3-08CF739B9047Q50898780-84800AAA-C133-4FD8-B3AF-D0E26B4A4443Q50903984-4B415580-0800-4C6D-8779-83A5C1D35D6CQ51048665-13C69FED-954A-457D-A9B4-194E124F0BCCQ51891856-59884507-24CB-4E0E-8A26-23AE8833501BQ51922500-4D2B519F-4F21-4DB9-81BD-3F027C98F418Q51953046-9D2D4876-E834-4932-9B7E-A2435B77355FQ51989222-08C3612F-7C2A-4CC0-9772-55BA07DE3FA5Q52086901-DEE3533A-35D3-40C1-8099-3930875A6BE4Q53176657-73692A91-02E6-4CDF-9FA7-D47589EBEFA9
P2860
Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI).
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Identifying multiple sclerosis ...... Cognitive Impairment (SEFCI).
@en
Identifying multiple sclerosis ...... ation for Cognitive Impairment
@nl
type
label
Identifying multiple sclerosis ...... Cognitive Impairment (SEFCI).
@en
Identifying multiple sclerosis ...... ation for Cognitive Impairment
@nl
prefLabel
Identifying multiple sclerosis ...... Cognitive Impairment (SEFCI).
@en
Identifying multiple sclerosis ...... ation for Cognitive Impairment
@nl
P2093
P356
P1433
P1476
Identifying multiple sclerosis ...... Cognitive Impairment (SEFCI).
@en
P2093
P304
P356
10.1212/WNL.45.4.718
P407
P577
1995-04-01T00:00:00Z